Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

CKIP-1

Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_111

Synonyms

Historical Background

CKIP-1 (CK2-interacting protein-1) was initially described on the basis of its interactions with protein kinase CK2 (Bosc et al. 2000). In this respect, the first publication on CKIP-1 described isolation of a cDNA encoding this novel protein from a human B-cell cDNA library using a yeast two-hybrid screen to identify interaction partners of protein kinase CK2. Interactions between CK2 and CKIP-1 were confirmed by co-immunoprecipitation experiments and in vitro interaction assays using recombinant and in vitro translated proteins. Prior to that report, a partial cDNA encoding its C-terminal 72 amino acids had been isolated from a mouse embryo cDNA library, using a yeast two-hybrid screen to identify interaction partners for the leucine zipper region of the c-Jun transcription factor (Chevray and Nathans 1992). Collectively, these reports suggested that the primary functions of CKIP-1 were mediated by interactions with other proteins within cells. Since these initial reports, subsequent studies have reinforced that suggestion by demonstrating that CKIP-1 interacts with a number of other cellular proteins and that CKIP-1 could be involved in a variety of distinct biological processes.

Domain Structure and Architecture

The human CKIP-1 cDNA encodes a protein of 409 amino acids with an N-terminal pleckstrin-homology (PH) domain and a C-terminal domain containing a putative leucine zipper (Fig. 1). The central region that separates the PH domain and leucine zipper contains a significant number of proline residues including P-X-X-P motifs that may be involved in protein interactions and S-P or T-P motifs that could be sites of phosphorylation for proline-directed protein kinases such as MAP kinases or cyclin-dependent kinases (CDKs). Homologs of CKIP-1 in other species, including mouse, rats, chickens, and zebrafish, contain the same general domain structure and a reasonably high level of conservation. For example, the deduced protein sequences of mouse, chicken, or zebrafish CKIP-1 display approximately 90%, 80%, and 60% identity to human CKIP-1, respectively. Independent reports have demonstrated that CKIP-1 has the capacity to form leucine-zipper-mediated dimers, an event that may regulate interactions with other cellular partners (Zhang et al. 2007; Tokuda et al. 2007).
CKIP-1, Fig. 1

Schematic illustration of the domain structure of CKIP-1. The pleckstrin homology (PH) domain, capping protein interaction (CPI) motif, and putative leucine zipper (LZ) are indicated. P-X-X-P motifs that may also be involved in protein-protein interactions are also marked

Regulation of CKIP-1

While a detailed understanding of its regulation remains incomplete, a number of potential mechanisms for controlling the activity of CKIP-1 have been reported. These mechanisms include both changes in its level of expression and posttranslational mechanisms. In terms of changes in its level of expression, CKIP-1 has been shown to be upregulated during muscle differentiation (Safi et al. 2004) and to be induced by cytokines (Zhang et al. 2007). Posttranslational mechanisms include PI3-kinase-dependent interactions between its PH domain and phosphatidylinositol 3-phosphate in the plasma membrane (Safi et al. 2004). By comparison, independent studies have demonstrated that CKIP-1 is constitutively localized to the plasma membrane and exhibits relatively nonspecific interactions with membrane phospholipids raising questions about its precise interactions with phosphatidylinositols (Olsten et al. 2004). It does not appear that the PH domain of CKIP-1 is exclusively involved in interactions with membrane phospholipids. In this respect, the PH domain of CKIP-1 has also been shown to be important for interactions with some of its protein partners, including CK2 and Akt (Olsten et al. 2004; Tokuda et al. 2007). In addition to its localization to the plasma membrane, it has also been reported that CKIP-1 can be localized within the cytoplasm and the nucleus of cultured cells (Bosc et al. 2000; Litchfield et al. 2001; Xi et al. 2010). In one instance, CKIP-1 has been identified as a substrate for caspase 3 following the induction of apoptosis (Zhang et al. 2005). In this situation, a C-terminal fragment of CKIP-1 is translocated to the nucleus where it represses AP-1 activity, presumably through interactions with c-Jun. An additional mechanism that may contribute to its regulation in cells is posttranslational modification including phosphorylation (Zhang et al. 2005, 2006) and potentially ubiquitination. From this perspective, a number of distinct phosphorylation sites and one additional ubiquitination site have been identified for CKIP-1 as summarized in the PhosphoSitePlus database (Hornbeck et al. 2014) that includes an analysis of data from the published literature and from global proteomic studies.

Biological Functions of CKIP-1

Based on its domain structure and absence of obvious sequence similarities to known catalytic domains, it has been proposed that CKIP-1 could be an adaptor protein or targeting protein that participates in cellular events through interactions with other cellular proteins (Litchfield et al. 2001; Canton et al. 2005; Canton and Litchfield 2006). Following its identification as a CK2-interacting protein (Bosc et al. 2000) and putative partner for the leucine zipper of the c-Jun transcription factor (Chevray and Nathans 1992), additional partners for CKIP-1 were identified (Fig. 2). CKIP-1 interacting proteins included other protein kinases such as ATM (Zhang et al. 2006) and Akt (Tokuda et al. 2007). As was the case with CK2, CKIP-1 was shown to recruit a proportion of ATM to the plasma membrane. Other interaction partners for CKIP-1 include the heterodimeric actin-capping protein comprised of CPα and CPβ (Canton et al. 2005, 2006; Hernandez-Valladares et al. 2010; Takeda et al. 2010), interferon-induced proteins IFP35 and Nmi (Zhang et al. 2007), and Smurf1 that is a HECT-type ubiquitin ligase involved in SMAD protein regulation in the bone morphogenetic protein (BMP) pathway (Barrios-Rodiles et al. 2005; Lu et al. 2008).
CKIP-1, Fig. 2

Interaction partners for CKIP-1 and consequences of interaction. Additional detail is presented in the text

In view of its relatively diverse collection of binding partners, it is perhaps not surprising that CKIP-1 appears to participate in a variety of biological events (Fig. 2). In this respect, when it is expressed in cells under the control of an inducible promoter, increased expression of CKIP-1 promotes changes in cell morphology and the actin cytoskeleton, presumably through its interactions with the actin-capping protein (Canton et al. 2005). Through its induction by cytokines and interactions with proteins such as IFP35 and Nmi, CKIP-1 has also been implicated in cytokine signaling (Zhang et al. 2007) as well as other aspects of inflammation and immune cell signaling (Sakamoto et al. 2014; Zhang et al. 2014). Since interfering with activation of the PI3-kinase pathway or the expression of CKIP-1 in C2C12 cells blocks differentiation, it appears that CKIP-1 is a component of PI3-Kinase-regulated muscle differentiation (Safi et al. 2004). Additional involvement with the PI3-kinase pathway comes from the demonstration that increased CKIP-1 expression results in impaired growth of tumor cells in vitro and in mouse Xenografts that is accompanied by inactivation of Akt (Tokuda et al. 2007). In addition to its involvement in these events, there is mounting evidence demonstrating that CKIP-1 has an important role in bone homeostasis (Lu et al. 2008), a function that may relate to its designation as an osteoclast maturation-associated gene (i.e., OC120). Through its interactions with Smurf1, CKIP-1 promotes an activation of the ubiquitin ligase activity of Smurf1 (Wang et al. 2012). Furthermore, in CKIP-1-deficient mice, a decrease in Smurf1 activity is accompanied by an age-dependent increase in bone mass. Confirmation of its role in bone formation comes from studies where bone mass was enhanced in rats in response to targeted delivery of CKIP-1-specific siRNA to osteogenic cells in rats (Zhang et al. 2012). In addition to these roles related to immune function, muscle, and bone, CKIP-1 has also been implicated in cardiac hypertrophy (Ling et al. 2012), tumor suppression (Nie et al. 2014), and adipogenesis (Li et al. 2014).

Summary

Since its original characterization as a CK2-interacting protein and as a putative partner for the leucine zipper of the c-Jun transcription factor, additional partners for CKIP-1 have been characterized. In conjunction with the identification of its partners, CKIP-1 has been implicated in a number of distinct biological events. Although it would appear that a comprehensive understanding of CKIP-1 and its regulation and functions is far from complete, its involvement in processes such as muscle differentiation, tumor growth, bone homeostasis, as well as cardiac hypertrophy and adipogenesis suggests that a detailed understanding of CKIP-1 could ultimately yield novel approaches for preventing or treating disease. It can also be envisaged that the involvement of CKIP-1 in processes that underlie human health and disease will spur more attention on its regulation and functional properties. Challenges for the future include efforts to elucidate its high-resolution structure, comprehensive identification of its cellular partners, and thorough evaluation of its expression levels at both gene and protein levels during development and in response to different stimuli. Collectively, this information will yield a more precise understanding of CKIP-1 and its role in biological processes that could ultimately instruct efforts to target its activity for the prevention or treatment of diseases such as cancer, musculoskeletal disorders, and heart disease.

References

  1. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL. High-throughput mapping of a dynamic signaling network in mammalian cells. Science. 2005;307:1621–5.CrossRefPubMedGoogle Scholar
  2. Bosc DG, Graham KC, Saulnier RB, Zhang C, Prober D, Gietz RD, Litchfield DW. Identification and characterization of CKIP-1, a novel pleckstrin homology-domain containing protein that interacts with protein kinase CK2. J Biol Chem. 2000;275:14295–306.CrossRefPubMedGoogle Scholar
  3. Canton DA, Litchfield DW. The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal. 2006;18:267–75.CrossRefPubMedGoogle Scholar
  4. Canton DA, Olsten ME, Kim K, Doherty-Kirby A, Lajoie G, Cooper JA, Litchfield DW. The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein. Mol Cell Biol. 2005;25:3519–34.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Canton DA, Olsten ME, Niederstrasser H, Cooper JA, Litchfield DW. The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein. J Biol Chem. 2006;281:36347–59.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Chevray PM, Nathans D. Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc Natl Acad Sci USA. 1992;89:5789–93.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Hernandez-Valladares M, Kim T, Kannan B, Tung A, Aguda AH, Larsson M, Cooper JA, Robinson RC. Structural characterization of a capping protein interaction motif defines a family of actin filament regulators. Nat Struct Mol Biol. 2010;17:497–503.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 2014;43:D512–20.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Li D, Zhu H, Liang C, Li W, Xing G, Ma L, Ding L, Zhang Y, He F, Zhang L. CKIP-1 suppresses the adipogenesis of mesenchymal stem cells by enhancing HDAC1-associated repression of C/EBPa. J Mol Cell Biol. 2014;6:368–79.CrossRefPubMedGoogle Scholar
  10. Ling S, Sun Q, Li Y, Zhang L, Zhang P, Wang X, Tian C, Li Q, Song J, Liu H, Kan G, Cao H, Huang Z, Nie J, Bai Y, Chen S, Li Y, He F, Zhang L, Li Y. CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A. Circulation. 2012;126:3028–40.CrossRefPubMedGoogle Scholar
  11. Litchfield DW, Bosc DG, Canton DA, Saulnier RB, Vilk G, Zhang C. Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners. Mol Cell Biochem. 2001;227:21–9.CrossRefPubMedGoogle Scholar
  12. Lu K, Yin X, Weng T, Xi S, Li L, Xing G, Cheng X, Yang X, Zhang L, He F. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat Cell Biol. 2008;10:994–1002.CrossRefPubMedGoogle Scholar
  13. Nie J, Liu L, Xing G, Zhang M, Wei R, Guo M, Li X, Xie P, Li L, He F, Han W, Zhang L. CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation. Oncogene. 2014;33:3677–87.CrossRefPubMedGoogle Scholar
  14. Olsten ME, Canton DA, Zhang C, Walton PA, Litchfield DW. The pleckstrin homology domain of CK2 interacting protein-1 is required for interactions and recruitment of protein kinase CK2 to the plasma membrane. J Biol Chem. 2004;279:42114–27.CrossRefPubMedGoogle Scholar
  15. Safi A, Vandromme M, Caussanel S, Valdacci L, Baas D, Vidal M, Brun G, Schaeffer L, Goillot E. Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation. Mol Cell Biol. 2004;24:1245–55.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Sakamoto T, Kobayashi M, Taka K, Shinohara M, Io K, Nagata K, Iwai F, Takiuchi Y, Arai Y, Yamashita K, Shindo K, Kadowaki N, Koyanagi Y, Takaori-Kondo A. CKIP-1 is an intrinsic regulator of T-cell activation through an interaction with CARMA1. PLoS One. 2014;9:e85762.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Takeda S, Minakata S, Koike R, Kawahata I, Narita A, Kitazawa M, Ota M, Yamakuni T, Maéda Y, Nitanai Y. Two distinct mechanisms for actin capping protein regulation – steric and allosteric inhibition. PLoS Biol. 2010;8:e1000416.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Tokuda E, Fujita N, Oh-hara T, Sato S, Kurata A, Katayama R, Itoh T, Takenawa T, Miyazono K, Tsuruo T. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res. 2007;67:9666–76.CrossRefPubMedGoogle Scholar
  19. Wang Y, Nie J, Wang Y, Zhang L, Lu K, Xing G, Xie P, He F, Zhang L. CKIP-1 couples Smurf1 ubiquitin ligase with Rpt6 subunit of proteasome to promote substrate degradation. EMBO Rep. 2012;13:1004–11.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Xi S, Tie Y, Lu K, Zhang M, Yin X, Chen J, Xing G, Tian C, Zheng X, He F, Zhang L. N-terminal PH domain and C-terminal auto-inhibitory region of CKIP-1 coordinate to determine its nucleus-plasma membrane shuttling. FEBS Lett. 2010;584:1223–30.CrossRefPubMedGoogle Scholar
  21. Zhang L, Xing G, Tie Y, Tang Y, Tian C, Li L, Sun L, Wei H, Zhu Y, He F. Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis. EMBO J. 2005;24:766–78.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Zhang L, Tie Y, Tian C, Xing G, Song Y, Zhu Y, Sun Z, He F. CKIP-1 recruits nuclear ATM partially to the plasma membrane through interaction with ATM. Cell Signal. 2006;18:1386–95.CrossRefPubMedGoogle Scholar
  23. Zhang L, Tang Y, Tie Y, Tian C, Wang J, Dong Y, Sun Z, He F. The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell Signal. 2007;19:932–44.CrossRefPubMedGoogle Scholar
  24. Zhang G, Guo B, Wu H, Tang T, Zhang BT, Zheng L, He Y, Yang Z, Pan X, Chow H, To K, Li Y, Li D, Wang X, Wang Y, Lee K, Hou Z, Dong N, Li G, Leung K, Hung L, He F, Zhang L, Qin L. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med. 2012;18:307–14.CrossRefPubMedGoogle Scholar
  25. Zhang L, Wang Y, Xiao F, Wang S, Xing G, Li Y, Yin X, Lu K, Wei R, Fan J, Chen Y, Li T, Xie P, Yuan L, Song L, Ma L, Ding L, He F, Zhang L. CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation. Cell Res. 2014;24:742–61.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Biochemistry, Schulich School of Medicine and DentistryThe University of Western OntarioLondonCanada
  2. 2.Department of Oncology, Schulich School of Medicine and DentistryThe University of Western OntarioLondonCanada